• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

Dominica Accepts TRIPS Health Amendment; Two More To Go?

29/11/2016 by William New, Intellectual Property Watch 2 Comments

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to email this to a friend (Opens in new window)
  • Click to print (Opens in new window)

The government of Dominica has deposited its instrument of acceptance of the 2005 so-called “paragraph 6” amendment to international intellectual property trade rules aimed at making it easier for countries to export affordable medical products to developing countries. Dominica’s signing brings the number of signers to 65 percent of WTO members, according to the WTO. Two-thirds of WTO members must accept it for the amendment to go into effect, but it is unclear exactly how many members that represents. It appears that two or three more members will tip the scale.

A street in the Dominica capital of Roseau. Will affordable medicines flow there?

A street in the Dominica capital of Roseau. Will affordable medicines flow there?

The amendment to the WTO Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) is a waiver to a rule that limits medical products made under compulsory licence to be predominantly for the domestic market. WTO has been encouraging members to accept it, despite misgivings about the amendment by some academics, health advocates and the generic drug industry (IPW, WTO/TRIPS, 14 November 2016). They argue that the waiver does not work and locking it in now would make it more difficult to find a solution that actually does work.

According to the list of members accepting the amendment, with Dominica, 79 of 164 WTO members, plus the European Union, have accepted it. But it is a little unclear whether the EU counts as 28 or 29 members – even before the Brexit departure of the United Kingdom from the union. According to a former WTO spokesperson, the WTO counts the EU as 28 members plus itself for a total of 29 (IPW, WTO/TRIPS, 14 April 2016). But the European Commission says the EU is only 28 total.

Assuming conservatively that the EU is 28 members, plus the 79 other members, would bring the total to 107. That is consistent with the WTO’s calculation that Dominica’s acceptance brings the total to 65 percent of members. A calculation shows 67 percent (two-thirds) of 164 members to be either 109 or 110 members, which would mean there only needs to be 2 or 3 more members before it goes into effect.

[Update:] The WTO considers that three more members are needed if EU members are agreed. According to WTO:

“Note that the European Commission had 27 member states at the time of its deposit in 2007. Equating the European Commission’s instrument to 28 acceptances (i.e. EC plus 27) and provided the Membership is on the record as endorsing such a counting method, the Protocol will enter into force upon receipt of an additional 3 legally valid instruments of acceptance.” [end update]

The full WTO press release is reprinted below:

Dominica accepts TRIPS amendment to ease poor countries’ access to affordable medicines

Dominica deposited its instrument of acceptance for the 2005 protocol amending the WTO’s Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) on 28 November 2016.

The protocol amending the TRIPS Agreement, which was agreed in 2005, is intended to formalize a decision to ease poorer WTO members’ access to affordable medicines. The protocol allows exporting countries to grant compulsory licences (one that is granted without the patent holder’s consent) to their generic suppliers to manufacture and export medicines to countries that cannot manufacture the needed medicines themselves. These licences were originally limited to predominantly supplying the domestic market.

At the most recent meeting of the Council for TRIPS on 8-9 November, the Chairperson, Ambassador Modest Jonathan Mero of Tanzania, urged WTO members that have not yet accepted the amendment to do so expeditiously. He noted that his call echoes “the multiple efforts Director-General Azevêdo and my predecessors have made since last year to secure the entry into force of the protocol. The Director-General, in his contacts, regularly emphasizes that this is not only a priority for the WTO, but represents a concrete contribution that WTO members could make to global efforts to strengthen the legal framework for access to medicines.”

With Dominica’s acceptance, over 65 per cent of WTO members have submitted their instruments of acceptance for the TRIPS protocol. The protocol will enter into force once two-thirds of the WTO membership has formally accepted it.

The up-to-date list and map of members that have accepted the protocol are available here.

More information on the issue of TRIPS and public health is available here.

 

Image Credits: Wikimedia

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to email this to a friend (Opens in new window)
  • Click to print (Opens in new window)

Related

William New may be reached at wnew@ip-watch.ch.

Creative Commons License"Dominica Accepts TRIPS Health Amendment; Two More To Go?" by Intellectual Property Watch is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Filed Under: IP Policies, Language, Themes, Venues, English, Health & IP, Patents/Designs/Trade Secrets, WTO/TRIPS

Comments

  1. Matthew Kennedy says

    01/12/2016 at 7:32 pm

    The TRIPS amendment may need a lot more acceptances to reach two-thirds of the WTO membership. EU member states are parties to the original TRIPS Agreement but most have not deposited an instrument of acceptance of the TRIPS amendment. That makes a big difference because there are 28 EU member states. The EU only says its member states are bound as a matter of EU law, but that is a different matter from WTO law. How do we know if other WTO Members are satisfied that the TRIPS amendment is binding on, say, Britain, home to two pharmaceutical giants, when there is no acceptance with a British signature on it?

    Reply

Trackbacks

  1. Links 30/11/2016: Git 2.11, GOG Surprise Tomorrow | Techrights says:
    30/11/2016 at 2:30 pm

    […] Dominica Accepts TRIPS Health Amendment; Two More To Go? […]

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2025 · Global Policy Reporting

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.